Cochlear (COH) Stock Price, News & Analysis

Company Overview

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 201,277 shs
• Average Volume: N/A
• Market Capitalization: $19.88 billion
• P/E Ratio: 55.90
• Dividend Yield: 1.35%
• Price Target: N/A
• Consensus Rating: N/A

COH Stock Analysis - Frequently Asked Questions

How were Cochlear's earnings last quarter?

Cochlear Limited (ASX:COH) posted its quarterly earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 19.70% and a net margin of 15.80%.

What other stocks do shareholders of Cochlear own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE).

Company Calendar

• Last Earnings: 2/19/2019
• Ex-Dividend for 4/13 Dividend: 3/19/2025
• Record date for 4/13 Dividend: 4/13/2025
• Dividend Payable: 4/13/2025
• Today: 5/29/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:COH
• CIK: N/A
• Web: www.cochlear.com
• Phone: +61-2-94286555
• Fax: N/A
• Employees: 4,996
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$5.43
• Trailing P/E Ratio: 55.90
• Forward P/E Ratio: N/A
• P/E Growth: 3.87
• Net Income: $356.80 million
• Net Margins: 15.80%
• Pretax Margin: N/A
• Return on Equity: 19.70%
• Return on Assets: 11.99%

Debt

• Debt-to-Equity Ratio: 13.24
• Current Ratio: 2.30
• Quick Ratio: 1.93

Sales & Book Value

• Annual Sales: $2.24 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 123.45
• Book Value: A$28.10 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 65,500,000
• Free Float: N/A
• Market Cap: $19.88 billion
• Optionable: Not Optionable
• Beta: 0.47